Literature DB >> 11197835

[Study of the radioprotective effects of TMG on teratogenic malformations in irradiated mice].

Y Gu1, T Hasegawa, H Kim, I Suzuki, T Mori, Y Yamamoto.   

Abstract

ICR mice fetuses in the organogenesis stage were used to clarify experimentally the mechanism of the protective effect of vitamin E derivant (TMG: 2-(alpha-D-Glucopyranosyl) methyl-2, -5, -7, -8-Teramethylchorman-6-working woman) on the effects of radiation. The authors paid careful attention to radiation, and the radioprotective effects of TMG on the induction of malformations was examined. Radiation is an important consideration because of its widespread use in the areas of medicine, nuclear energy, and industry. Malformations induced by radiation at the organogenesis stage, skeletal malformations, and the effects at the cellular level of embryos were examined in this research. Further, the mechanism of the protection effect of TMG against radiation-induced malformations was analyzed and observed experimentally. Thus, this study was done to provide fundamental data on the radioprotective agent TMG. It was clear that TMG exerted radioprotective effects against embryonic death and the rate of teratogenesis when administered before exposure. Such effects were also exerted against skeletal malformations and fetal body weight. In summary, radioprotective effects were observed at the whole-body level as well as at the cellular level.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11197835

Source DB:  PubMed          Journal:  Nihon Igaku Hoshasen Gakkai Zasshi        ISSN: 0048-0428


  2 in total

1.  Hydrosoluble antioxidants by enzymatic glucosylation of a vitamin E derivative using marine α-D-glucosidase from Aplysia fasciata.

Authors:  Annabella Tramice; Giuseppina Andreotti; Antonio Trincone
Journal:  Mar Biotechnol (NY)       Date:  2011-01-06       Impact factor: 3.619

Review 2.  Radio-protective role of antioxidant agents.

Authors:  Alireza Shirazi; Ehsan Mihandoost; Seied Rabie Mahdavi; Mehran Mohseni
Journal:  Oncol Rev       Date:  2012-10-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.